← Back to Search

Platelet Rich Plasma

PRP Group for Pressure Sore

N/A
Waitlist Available
Led By Louis Thibodeaux, MD,FACCWS
Research Sponsored by ACR Biologics, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 20 weeks
Awards & highlights

Study Summary

This trial will test whether autologous platelet rich plasma (PRP) can speed up the healing of chronic wounds.

Eligible Conditions
  • Pressure Sore
  • Foot Ulcer
  • Venous Ulcers

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~20 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 20 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Wound Closure

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: PRP GroupActive Control1 Intervention
Patients will receive weekly PRP treatments
Group II: Standard of CarePlacebo Group1 Intervention
Patients will receive weekly standard of care.

Find a Location

Who is running the clinical trial?

ACR Biologics, LLCLead Sponsor
Louis Thibodeaux, MD,FACCWSPrincipal InvestigatorTriHealth Hatton Research Institute | Bethesda North Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~8 spots leftby Apr 2025